AF Screen International Collaboration
AF Screen International Collaboration
For Realizing Vision of ZERO Cerebro-Cardiovascular Events, OMRON Healthcare Sponsored the first annual meeting of AF Screen International Collaboration
OMRON Healthcare Co., Ltd. August 29, 2023 — OMRON Healthcare Co., Ltd. (hereinafter referred to as the Company) based in Muko, Kyoto Prefecture, has announced the official sponsorship of the first annual meeting of the AF Screen International Collaboration, a collaborative group that was established to promote discussion and research about screening for unknown or under-treated atrial fibrillation (AF) as a way to reduce stroke and death.
Early detection of AF is the key to solve challenges of heart disease and stroke
World Health Organisation (WHO) report shows that the global leading cause of death is heart disease, followed by stroke. The number of cerebrovascular and cardiovascular diseases continues to rise due to the accelerating aging of the population and lifestyle changes caused by the economic growth. As the Company believes the early detection of AF is a key to solve these health-related challenges, it has dedicated to communicating the importance of a blood pressure control by using home blood pressure monitor with a wider audience. In 2020, "Complete (TM)," an upper-arm blood pressure monitor with built-in ECG technology was released and at the same time, the Company launched a couple of initiatives by using home ECG monitors for detecting AF at an early stage. In addition, the OMRON Academy, a learning programme for healthcare professionals, has been actively implemented to raise awareness of the disease.
The AF Screen International Collaboration
The AF Screen International Collaboration is a research group that consists of more than 200 members from 40 countries led by globally notable professionals such as Professor Ben Freedman of University of Sydney. It has committed to the disease awareness activities aimed at early detection of AF, and the advocacy for implementation of AF screening programs, tailored to the medical systems of individual countries.
First annual meeting sponsored by OMRON
The Company sponsored the first annual meeting of the AF Screen International Collaboration, and during the meeting, physicians presented the latest findings in early detection of AF as well as the risk of developing AF in hypertensive patients and agreed to jointly conduct future disease awareness activities
For realizing the vision of Going for ZERO, achieving zero cerebro-cardiovascular events, the Company has committed to support a better hypertension treatment and early detection of AF in collaboration with healthcare professionals and researchers.
The annual meeting of AF Screen International Collaboration
Title: European Society of Cardiology 2023
Date: Thursday 24 August 2023 (CEST)
Venue: Hilton Amsterdam Airport Schiphol, Amsterdam
Official website: https://www.afscreen.org
*AF screening conference is organized on behalf of the AF SCREEN international collaboration by the Translational Medicine Academy (TMA), a non-profit foundation based in Switzerland (www.tmacademy.org)
Organizer: Prof. Ben Freedman
Director External Affairs at the Heart Research Institute, Charles Perkins Centre and Group Leader of the Heart Rhythm and Stroke Prevention Group. Professor of Cardiology at The University of Sydney and former head of Department of Cardiology
- Early AF detection and Outcomes other than stroke
- AF-SCREEN Year in review
- Hypertension and AF
- Combined Hypertension + AF White paper
- UPDATE on continuing screening RCTs and IP
Public Relations Department
OMRON Healthcare Co., Ltd.
Address: 53 Kunotsubo, Terado-cho, Muko City, Kyoto 617-0002, Japan